Guidelines on surveillance among populations most at risk for HIV
Guidelines on surveillance among populations most at risk for HIV
Guidelines on surveillance among populations most at risk for HIV
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Appendix B: Glossary and acr<strong>on</strong>ymsAIDSActive <strong>surveillance</strong>AIDS case<strong>surveillance</strong>An<strong>on</strong>ymousAntiretroviral drugsAntiretroviral therapy(ART)Behavioural<strong>surveillance</strong>BiasBridging popul<strong>at</strong>i<strong>on</strong>sCase reportingC<strong>on</strong>centr<strong>at</strong>ed <strong>HIV</strong>epidemicC<strong>on</strong>fidentialityC<strong>on</strong>veniencesamplingDemographicin<strong>for</strong>m<strong>at</strong>i<strong>on</strong>Denomin<strong>at</strong>orEpidemicEpidemiologyGeneralized <strong>HIV</strong>epidemicHigh-<strong>risk</strong> behavioursHighly activeantiretroviral therapy(HAART)<strong>HIV</strong>L<strong>at</strong>e stage of <strong>HIV</strong> infecti<strong>on</strong>, including the development of <strong>on</strong>e or more opportunistic illnesses (illnessesth<strong>at</strong> occur because of low levels of CD4 lymphocytes or immunodeficiency)A system in which health authority pers<strong>on</strong>nel take the lead in identifying and reporting cases, as opposedto “passive <strong>surveillance</strong>”The identifi c<strong>at</strong>i<strong>on</strong> and reporting of pers<strong>on</strong>s meeting the definiti<strong>on</strong> of an AIDS case to permit public healthauthorities to track the disease over time. Also known as ”AIDS case reporting”Having no known name or identity. For example, removing all pers<strong>on</strong>al identifying in<strong>for</strong>m<strong>at</strong>i<strong>on</strong> from asample th<strong>at</strong> will be tested <strong>for</strong> <strong>HIV</strong>, in order to protect the p<strong>at</strong>ient’s identityDrugs used to fi ght infecti<strong>on</strong>s caused by retroviruses such as <strong>HIV</strong>Tre<strong>at</strong>ment with drugs th<strong>at</strong> inhibit the ability of <strong>HIV</strong> to multiply in the bodySurveys of behaviour th<strong>at</strong> may result in acquiring <strong>HIV</strong>. This may involve asking a sample of people about<strong>risk</strong> behaviours such as sexual practices and drug use.A system<strong>at</strong>ic error in the collecti<strong>on</strong> or interpret<strong>at</strong>i<strong>on</strong> of d<strong>at</strong>aPers<strong>on</strong>s bel<strong>on</strong>ging to high-<strong>risk</strong> subpopul<strong>at</strong>i<strong>on</strong>s who interact with people <strong>at</strong> lower <strong>risk</strong> in the generalpopul<strong>at</strong>i<strong>on</strong>, making it more likely <strong>for</strong> the <strong>HIV</strong> epidemic to shift from high-<strong>risk</strong> (“c<strong>on</strong>centr<strong>at</strong>ed”) popul<strong>at</strong>i<strong>on</strong>sto the general popul<strong>at</strong>i<strong>on</strong>A <strong>surveillance</strong> system in which pers<strong>on</strong>s who are identified as meeting the case defi niti<strong>on</strong> are reported topublic health authoritiesThe epidemic st<strong>at</strong>e in which <strong>HIV</strong> has spread to a high level in a defined subpopul<strong>at</strong>i<strong>on</strong> but is not wellestablished in the general popul<strong>at</strong>i<strong>on</strong>. This epidemic st<strong>at</strong>e is characterized by an <strong>HIV</strong> prevalence th<strong>at</strong> isc<strong>on</strong>sistently >5% in <strong>at</strong> least <strong>on</strong>e defined subpopul<strong>at</strong>i<strong>on</strong>, but 1% in pregnant women.Behaviours th<strong>at</strong> increase the <strong>risk</strong> of a pers<strong>on</strong> c<strong>on</strong>tracting a diseaseThe use of <strong>at</strong> least three antiretroviral drugs in combin<strong>at</strong>i<strong>on</strong> to suppress viral replic<strong>at</strong>i<strong>on</strong> and progressi<strong>on</strong> of<strong>HIV</strong> disease by reducing the viral load to undetectable levelsAcr<strong>on</strong>ym <strong>for</strong> human immunodefi ciency virus36